149 related articles for article (PubMed ID: 35812518)
1. Use of a Non-parametric Bayesian Method to Model Health State Preferences: An Application to Polish and Irish EQ-5D-5L Valuations.
Kharroubi SA; Kelleher D
Front Public Health; 2022; 10():917728. PubMed ID: 35812518
[TBL] [Abstract][Full Text] [Related]
2. Examining the Association between Polish Migrant Status and Health Preferences Using a Novel Application of a Smaller Design EQ-5D-5L Valuation Study.
Kelleher D; Kharroubi S; Doherty E; Baio G; O'Neill C
Pharmacoecon Open; 2022 May; 6(3):425-435. PubMed ID: 35080756
[TBL] [Abstract][Full Text] [Related]
3. Bayesian modeling of health state preferences: could borrowing strength from existing countries' valuations produce better estimates.
Kharroubi SA; Beyh Y
Eur J Health Econ; 2021 Jul; 22(5):773-788. PubMed ID: 33761028
[TBL] [Abstract][Full Text] [Related]
4. Examining the transnational health preferences of a group of Eastern European migrants relative to a European host population using the EQ-5D-5L.
Kelleher D; Barry L; Hobbins A; O'Neill S; Doherty E; O'Neill C
Soc Sci Med; 2020 Feb; 246():112801. PubMed ID: 31972377
[TBL] [Abstract][Full Text] [Related]
5. Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe.
Golicki D; Jakubczyk M; Graczyk K; Niewada M
Pharmacoeconomics; 2019 Sep; 37(9):1165-1176. PubMed ID: 31161586
[TBL] [Abstract][Full Text] [Related]
6. Bayesian nonparametric estimation of EQ-5D utilities for United States using the existing United Kingdom data.
Kharroubi SA
Health Qual Life Outcomes; 2017 Oct; 15(1):195. PubMed ID: 28985757
[TBL] [Abstract][Full Text] [Related]
7. Valuation of preference-based measures: can existing preference data be used to generate better estimates?
Kharroubi SA
Health Qual Life Outcomes; 2018 Jun; 16(1):116. PubMed ID: 29866108
[TBL] [Abstract][Full Text] [Related]
8. Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?
Kharroubi SA; Rowen D
Eur J Health Econ; 2019 Mar; 20(2):245-255. PubMed ID: 29980950
[TBL] [Abstract][Full Text] [Related]
9. Public versus patient health preferences: protocol for a study to elicit EQ-5D-5L health state valuations for patients who have survived a stay in intensive care.
Halling CMB; Gudex C; Perner A; Jensen CE; Gyrd-Hansen D
BMJ Open; 2022 May; 12(5):e058500. PubMed ID: 35613809
[TBL] [Abstract][Full Text] [Related]
10. Modelling a preference-based index for EQ-5D using a non-parametric Bayesian method.
Kharroubi SA; Daher CA
Qual Life Res; 2018 Nov; 27(11):2841-2850. PubMed ID: 30008157
[TBL] [Abstract][Full Text] [Related]
11. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
12. Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study.
Sayah FA; Bansback N; Bryan S; Ohinmaa A; Poissant L; Pullenayegum E; Xie F; Johnson JA
Qual Life Res; 2016 Jul; 25(7):1679-85. PubMed ID: 26659899
[TBL] [Abstract][Full Text] [Related]
13. 3125 steps to perfect health: a nonparametric approach to developing the EQ-5D-5L value set.
Thomas S; Johnson JA; Xie F
Qual Life Res; 2020 Nov; 29(11):3109-3118. PubMed ID: 32705459
[TBL] [Abstract][Full Text] [Related]
14. Bayesian Models with Spatial Correlation Improve the Precision of EQ-5D-5L Value Sets.
Che M; Xie F; Thomas S; Pullenayegum E
Med Decis Making; 2023 Jul; 43(5):587-594. PubMed ID: 37243474
[TBL] [Abstract][Full Text] [Related]
15. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
16. Modeling SF-6D Health Utilities: Is Bayesian Approach Appropriate?
Kharroubi SA
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444157
[TBL] [Abstract][Full Text] [Related]
17. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
Kharroubi SA; O'Hagan A; Brazier JE
Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
[TBL] [Abstract][Full Text] [Related]
18. Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework.
Kharroubi SA; Beyh YS; Brazier J; Yang Y
Qual Life Res; 2020 Jun; 29(6):1495-1507. PubMed ID: 32016681
[TBL] [Abstract][Full Text] [Related]
19. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.
Rencz F; Brodszky V; Gulácsi L; Golicki D; Ruzsa G; Pickard AS; Law EH; Péntek M
Value Health; 2020 Sep; 23(9):1235-1245. PubMed ID: 32940242
[TBL] [Abstract][Full Text] [Related]
20. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
